Stephen Flatt - 18 Feb 2022 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Role
CEO, Director
Signature
/s/ Stephen F. Flatt by Kristina R. Hulsey, P.O.A.
Issuer symbol
NHC
Transactions as of
18 Feb 2022
Transactions value $
$0
Form type
4
Filing time
23 Feb 2022, 15:37:32 UTC
Previous filing
04 Jan 2022
Next filing
01 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NHC Common Stock 51.5K 18 Feb 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NHC Option to Purchase Common Stock Award $0 +14.2K $0.00 14.2K 18 Feb 2022 Common Stock 14.2K $63.96 Direct F1, F2
holding NHC Option to Purchase Common Stock 5K 18 Feb 2022 Common Stock 5K $72.94 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options were granted pursuant to the Company's 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
F2 This option will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 18, 2023; one-third (1/3) will vest on February 18, 2024; and the final one-third (1/3) will vest on February 18, 2025.